Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion
Kevin Grundy

Kevin Grundy Analyst Performance

Managing Director at BNP Paribas Exane

Kevin Grundy is a stock analyst at BNP Paribas Exane focused in the consumer staples sector, covering 21 publicly traded companies. Over the past year, Kevin Grundy has issued 10 stock ratings, including buy, hold, and sell recommendations. While full access to Kevin Grundy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Kevin Grundy's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
156 Last 12 Years
Buy Recommendations
67.10% 104 Buy Ratings
Companies Covered
21 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy1.3%2 ratings
Buy65.8%102 ratings
Hold26.5%41 ratings
Sell6.5%10 ratings

Out of 155 total stock ratings issued by Kevin Grundy at BNP Paribas Exane, the majority (65.8%) have been Buy recommendations, followed by 26.5% Hold, 6.5% Sell, and 1.3% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
61.9% of companies on NYSE
13 companies
NASDAQ
38.1% of companies on NASDAQ
8 companies

Kevin Grundy, an analyst at BNP Paribas Exane, currently covers 21 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Consumer Staples
19 companies
90.5%
Healthcare
1 company
4.8%
Consumer Discretionary
1 company
4.8%

Kevin Grundy of BNP Paribas Exane specializes in stock coverage within the Consumer Staples sector, with additional focus on Healthcare and Consumer Discretionary companies.

Coverage Industries

IndustryPercentage
BEVERAGES
10 companies
47.6%
PERSONAL CARE PRODUCTS
4 companies
19.0%
HOUSEHOLD PRODUCTS
4 companies
19.0%
PHARMACEUTICALS
1 company
4.8%
HOUSEHOLD DURABLES
1 company
4.8%
FOOD PRODUCTS
1 company
4.8%

Kevin Grundy's Ratings History at BNP Paribas Exane

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
0 Results
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
10/23/2026Boost Price Target$161.29$189.00Outperform
Kimberly-Clark Corporation stock logo
KMB
Kimberly-Clark
10/16/2026Boost Price Target$104.65$110.00Neutral
PepsiCo, Inc. stock logo
PEP
PepsiCo
10/9/2026Lower Price Target$126.01$157.00Outperform
PepsiCo, Inc. stock logo
PEP
PepsiCo
9/23/2026Lower Price Target$129.90$161.00Outperform
Keurig Dr Pepper, Inc stock logo
KDP
Keurig Dr Pepper
8/10/2026Boost Price Target$34.78$29.00Neutral
The Clorox Company stock logo
CLX
Clorox
7/20/2026Lower Price Target$95.73$95.00Neutral
PepsiCo, Inc. stock logo
PEP
PepsiCo
7/8/2026Lower Price Target$144.60$183.00Outperform
Brown-Forman Corporation stock logo
BF.B
Brown-Forman
6/5/2026Boost Price Target$26.15$20.00Underperform
Celsius Holdings Inc. stock logo
CELH
Celsius
5/26/2026Reiterated Rating$30.28$57.00Outperform
Keurig Dr Pepper, Inc stock logo
KDP
Keurig Dr Pepper
4/22/2026Upgrade$26.44$28.00Neutral
Keurig Dr Pepper, Inc stock logo
KDP
Keurig Dr Pepper
9/22/2025Downgrade$27.11Underperform
Procter & Gamble Company (The) stock logo
PG
Procter & Gamble
8/15/2025Reiterated Rating$155.08$177.00Outperform
CocaCola Company (The) stock logo
KO
CocaCola
7/21/2025Reiterated Rating$70.12$83.00Outperform